Skip to main content
Erschienen in: ästhetische dermatologie & kosmetologie 4/2019

21.08.2019 | Alopezie | cme fortbildung

Update zum Haarausfall

Behandlung der Alopecia androgenetica

verfasst von: Prof. Dr. Tobias W. Fischer

Erschienen in: ästhetische dermatologie & kosmetologie | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die androgenetische Alopezie gehört bei vielen Männern zum Älterwerden, aber auch bei Frauen tritt Alopezie auf. Für die Behandlung kommen etablierte und aufstrebende Optionen infrage — wenn der Haarausfall gestoppt ist, zudem auch eine Haartransplantation.
Literatur
1.
Zurück zum Zitat Kanti V et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men — short version. J Eur Acad Dermatol Venereol. 2018; 32: 11–22CrossRef Kanti V et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men — short version. J Eur Acad Dermatol Venereol. 2018; 32: 11–22CrossRef
2.
Zurück zum Zitat Suchonwanit P et al. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25 % finasteride admixed with 3 % minoxidil vs. 3 % minoxidil solution in the treatment of male androgenetic alopecia. J Eur Acad Dermatol Venereol. 2018; https://doi.org/10.1111/jdv.15171CrossRef Suchonwanit P et al. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25 % finasteride admixed with 3 % minoxidil vs. 3 % minoxidil solution in the treatment of male androgenetic alopecia. J Eur Acad Dermatol Venereol. 2018; https://​doi.​org/​10.​1111/​jdv.​15171CrossRef
3.
Zurück zum Zitat Price V et al. e: Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol. 2000; 43: 768–76CrossRef Price V et al. e: Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol. 2000; 43: 768–76CrossRef
5.
Zurück zum Zitat Hausauer AK, Jones DH. Evaluating the Efficacy of Different Platelet-Rich Plasma Regimens for Management of Androgenetic Alopecia: A Single-Center, Blinded, Randomized Clinical Trial. Dermatol Surg. 2018; 44: 1191–200CrossRef Hausauer AK, Jones DH. Evaluating the Efficacy of Different Platelet-Rich Plasma Regimens for Management of Androgenetic Alopecia: A Single-Center, Blinded, Randomized Clinical Trial. Dermatol Surg. 2018; 44: 1191–200CrossRef
6.
Zurück zum Zitat Giordano S et al. A Meta-analysis On Evidence Of Platelet-rich Plasma for Androgenetic Alopecia. Int J Trichology. 2018; 10: 1–10CrossRef Giordano S et al. A Meta-analysis On Evidence Of Platelet-rich Plasma for Androgenetic Alopecia. Int J Trichology. 2018; 10: 1–10CrossRef
7.
Zurück zum Zitat Kramer ME, Keaney TC. Systematic review of platelet-rich plasma (PRP) preparation and composition for the treatment of androgenetic alopecia. J Cosmet Dermatol. 2018; 17: 666–71CrossRef Kramer ME, Keaney TC. Systematic review of platelet-rich plasma (PRP) preparation and composition for the treatment of androgenetic alopecia. J Cosmet Dermatol. 2018; 17: 666–71CrossRef
8.
Zurück zum Zitat Fischer TW et al. Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. Br J Dermatol. 2004; 150: 341–5CrossRef Fischer TW et al. Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. Br J Dermatol. 2004; 150: 341–5CrossRef
9.
Zurück zum Zitat Fischer TW et al. Topical melatonin for treatment of androgenetic alopecia. Int J Trichology. 2012; 4: 236–45CrossRef Fischer TW et al. Topical melatonin for treatment of androgenetic alopecia. Int J Trichology. 2012; 4: 236–45CrossRef
10.
Zurück zum Zitat Hatem S et al. Melatonin vitamin C-based nanovesicles for treatment of androgenic alopecia: Design, characterization and clinical appraisal. Eur J Pharm Sci. 2018; 122: 246–53CrossRef Hatem S et al. Melatonin vitamin C-based nanovesicles for treatment of androgenic alopecia: Design, characterization and clinical appraisal. Eur J Pharm Sci. 2018; 122: 246–53CrossRef
11.
Zurück zum Zitat Hatem S et al. Clinical cosmeceutical repurposing of melatonin in androgenic alopecia using nanostructured lipid carriers prepared with antioxidant oils. Expert Opin Drug Deliv. 2018; 15: 927–35CrossRef Hatem S et al. Clinical cosmeceutical repurposing of melatonin in androgenic alopecia using nanostructured lipid carriers prepared with antioxidant oils. Expert Opin Drug Deliv. 2018; 15: 927–35CrossRef
12.
Zurück zum Zitat Dhurat R et al. An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2 % versus Minoxidil 5 % Solution in Male Androgenetic Alopecia. Skin Pharmacol Physiol. 2017; 30: 298–305CrossRef Dhurat R et al. An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2 % versus Minoxidil 5 % Solution in Male Androgenetic Alopecia. Skin Pharmacol Physiol. 2017; 30: 298–305CrossRef
13.
Zurück zum Zitat Fischer TW, Hipler UC, Elsner P. Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro. Int J Dermatol. 2007; 46: 27–35CrossRef Fischer TW, Hipler UC, Elsner P. Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro. Int J Dermatol. 2007; 46: 27–35CrossRef
14.
Zurück zum Zitat Fischer TW et al. Differential effects of caffeine on hair shaft elongation, matrix and outer root sheath keratinocyte proliferation, and transforming growth factor-β2/insulin-like growth factor-1-mediated regulation of the hair cycle in male and female human hair follicles in vitro. Br J Dermatol. 2014; 171: 1031–43CrossRef Fischer TW et al. Differential effects of caffeine on hair shaft elongation, matrix and outer root sheath keratinocyte proliferation, and transforming growth factor-β2/insulin-like growth factor-1-mediated regulation of the hair cycle in male and female human hair follicles in vitro. Br J Dermatol. 2014; 171: 1031–43CrossRef
Metadaten
Titel
Update zum Haarausfall
Behandlung der Alopecia androgenetica
verfasst von
Prof. Dr. Tobias W. Fischer
Publikationsdatum
21.08.2019
Verlag
Springer Medizin
Erschienen in
ästhetische dermatologie & kosmetologie / Ausgabe 4/2019
Print ISSN: 1867-481X
Elektronische ISSN: 2198-6517
DOI
https://doi.org/10.1007/s12634-019-0073-0

Weitere Artikel der Ausgabe 4/2019

ästhetische dermatologie & kosmetologie 4/2019 Zur Ausgabe

kurz & knapp

kurz & knapp

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.